A leading biopharma company and makers of rapid delivery innovation for life-saving medicines - Nasus Pharma - stands behind its nasal spray, Taffix, reassuring the public of its safety and clinical efficacy. Taffix is built on an existing, proven, medical technology, which is already used in many nasal sprays to combat allergies and the common cold viruses.

Contrary to the wording in an email regarding Taffix Nasal Spray sent to customers in some countries by a retail company selling the product, Taffix is totally safe and legitimately available for sale in Europe by reference to its valid European Conformity market.

Dr Dalia Megiddo, co-founder and chief executive officer of Nasus Pharma, stresses: “Taffix is safe and legally marketed in Europe under CE certification as an over-the-counter general medical device product. It is indicated for the use as a safe, protective mechanical barrier against allergens and viruses within the nasal cavity. Manufactured to the strictest of compliance to all regulatory requirements, Taffix has been used by hundreds of thousands of people across the globe and there have been no health or safety concerns reported in relation to its intended conditions of use.

“Confusion has arisen because the Spanish authorities have taken the view that Taffix should be classified as a Medical Device Class III and not Class I product in Spain. This opinion is not consistent with the classification position of the countries within the European Union (EU) and of every country in the world that has approved Taffix. While we respect the Spanish Ministry position, we do not agree with it. Guided by all the experts we work with; we do not accept the validity of the Spanish Agency’s assessment and will be working closely with the authority on this matter.”

Dr Dalia Megiddo adds: “As a company, safety and clinical efficacy is best practice which is why we have tested Taffix thoroughly. ”

Sold in over 20 countries across Europe, America, Asia and Africa, Taffix is not a replacement for masks, it is an additional layer of self-care protection, particularly useful in high-risk settings such as any enclosed space.

March 17th 2021
Nasus Pharma Ltd.